Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10506 in Chinese Adult Participants With Insomnia Disorder
NCT06279286Phase 2Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- May 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10506 in insomnia disorder, sponsored by Hansoh Pharmaceutical Group. Planned start May 2024; status: not yet recruiting.
02
Drugs
HS-10506
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT06279286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06279286.